FSSAI Issues Updated Final List Of Approved RAFT-Kits

New Delhi : FSSAI has issued an updated final list of approved Rapid Analytical Food Testing (RAFT)-Kits, Equipment or Methods. A total of 75 RAFT kits, equipment, or methods were listed to be used for screening and surveillance purposes.

These methods/kits/equipment were approved by the FSSAI across six product categories including edible oils, milk, water & alcoholic beverages, meat & meat products, fish & fish products, raw including vegetable & finished products and automated system for rapid detection of pathogens in food matrices.

The FSSAI has constituted a committee for scrutinisation of applications for Rapid Analytical Food Testing (RAFT) Kit/ Equipment/ Method. The recommendations of the RAFT committee were ratified by the Scientific Panel on Methods of Sampling and Analysis and approved by the Competent Authority before adoption.

“The recommended rapid kit/equipment/method meets the requirements of the Food Safety and Standard Regulations and validated against International Standards,” says FSSAI’s statement.

The statement added that the purpose of the approval by FSSAI to RAFT Kit/Equipment/Method was to facilitate carrying out on the spot field testing by Food Safety Officers (FSOs) or Mobile Testing Labs or to improve speed and reduce testing costs in food laboratories.

“The rapid food testing kit/equipment/method ensure “faster, better, cheaper” real-time testing of food. The rapid food testing kit/equipment/ method are better in terms of their size, faster in terms of their total run time and cheaper in terms of cost effectiveness as compared to conventional methods. The rapid food testing kit/equipment approved by FSSAI is to be used for screening and surveillance purposes only,” reads the statement.

[pdf-embedder url=”https://medicarepharmabusiness.com/wp-content/uploads/2022/05/Status_RAFT_Applications_31_03_2022-140522080838.pdf”]

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre